LET Gel Topical Anesthetic Recalled Due to Incorrect Product Formulation
Right Value Drug Stores is recalling LET Gel topical anesthetic syringes nationwide due to incorrect product formulation. Patients should not use affected syringes and should consult their healthcare provider.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall for an incorrect product formulation with no reported illnesses or injuries. Class III recalls are typically low to moderate severity and are often voluntary precautionary measures.
Plain-English summary
Right Value Drug Stores, LLC is recalling LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel) in 3mL single-use syringes distributed in 10-pack boxes. The recall is due to an incorrect product formulation.
The product was distributed nationwide. Approximately 190 syringes with lot number 09202023@7 (expiration date March 18, 2024) were affected. Healthcare facilities and patients who received this product may have been impacted.
Do not use the affected syringes. If you have received or used this product, contact your healthcare provider or dentist immediately to discuss your treatment. Return any unused product to the pharmacy where it was obtained.
The recalled product
- Product
- LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1
- Manufacturer
- Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop
- Category
- Drug — Topical Anesthetic
- Hazard
- product-mix-up
- formulation-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: 09202023@7
- Exp 03/18/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27